MIRA INFORM REPORT

 

 

Report No. :

489202

Report Date :

05.02.2018

 

 

IDENTIFICATION DETAILS

 

Name :

S KANT HEALTHCARE LIMITED (w.e.f.14.03.1996)

 

 

Formerly Known As :

SEAPRINCE INVESTRADE PRIVATE LIMITED

 

 

Registered Office :

A/3, Shivsagar Estate, North Wing, Dr. Annie Besant Road, Mumbai – 400018, Maharashtra

Tel. No.:

91-22-66227575

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

18.03.1996

 

 

Com. Reg. No.:

11-098246

 

 

Capital Investment / Paid-up Capital :

INR 9.800 Million

 

 

CIN No.:

[Company Identification No.]

U24230MH1996PLC098246

 

 

IEC No.:

0397045166

 

 

GSTIN/UIN:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAECS5406P

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacture of medicinal substances used in the manufacture of pharmaceuticals antibiotics, endocrine products, basic vitamins, opium derivatives, sulpha drugs, serums and plasmas, salicylic acid, its salts and esters, glycosides and vegetable alkaloids, chemically pure suger etc. (Registered Activity)

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 1300000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 1996. The company is a manufacturer of pharmaceutical formulations and bulk drugs.

 

As per the financial records of 2017, the company has achieved a favourable growth of 22.38% in its revenue as compared to the previous year’s revenue and has gained a fair profitability margin of 6.07%.

 

The company possesses healthy financial position marked by sound net worth base along with low debt balance sheet profile and comfortable liquidity parameters.

 

Rating takes into consideration the company’s good Earnings Per Share (EPS) of INR 8621.24 as against its Face Value (FV) of INR 1000.

 

Business is active. Payment seems to be regular and as per commitment.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Long-term Rating=BBB (Suspended)

Rating Explanation

Moderate degree of safety and moderate credit risk

Date

July, 2016

 

Rating Agency Name

ICRA

Rating

Short-term Rating=A3+ (Suspended)

Rating Explanation

Moderate degree of safety and higher credit risk

Date

July, 2016

 

Reason for suspension: Absence of requisite information from the subject

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 05.02.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED BY

 

Name :

Mr. Roshan

Designation :

Office Executive

Contact No.:

91-22-66227575

Date :

03.02.2018

 

 

LOCATIONS

 

Registered Office/Head office :

A/3, Shivsagar Estate, North Wing, Dr. Annie Besant Road, Mumbai – 400018, Maharashtra, India

Tel. No.:

91-22-66227575

Fax No.:

91-22-66227500 / 66227600

E-Mail :

samir@sk1932.com

skhl@sk1932.com   

skae@sk1932.com

info@sk1932.com

Website :

http://skant.com

http://www.sk1932.com

 

 

Regulatory Office :

Mehta Mahal, Ground Floor 15 Matthew Road Opera House, Mumbai – 400004, Maharashtra, India

Tel. No.:

91-22-66172503

E-Mail :

reema@sk1932.com

 

Factory :

Plot No. 1802 – 1805, GIDC Phase III, Vapi – 396195, Gujrat, India

Tel. No.:

91-260-2422516 / 7 / 8

Fax No.:

91-260-2430527

E-Mail :

mahesh@skant.com

skhcl@skant.com

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Bharat Nemchand Shah

Designation :

Director

Address :

4th Floor, Room No.15, Bharatiya Bhavan, Netaji Subhash Marg, Marine Drive, Mumbai - 400020, Maharashtra, India

Date of Birth/Age :

06.09.1946

Date of Appointment :

28.04.2004

PAN No.:

ADUPS8329M

DIN No.:

00083354

Other Directorship:

CIN/FCRN

COMPANY NAME

BEGIN DATE

END DATE

L24230MH1960PLC011586

ANUH PHARMA LIMITED

29/10/1980

-

U24230MH1990PTC057922

PRAGATI PHARMA PRIVATE LIMITED

28/04/2004

-

U24230MH1994PTC080562

S KANT CHEMICALS PRIVATE LIMITED

24/08/1994

-

 

 

Name :

Mr. Samir Jayantilal Shah

Designation :

Director

Address :

3-B, Suvas Apartment, Rungta Lane, 68. F, Nepeansea Road, Mumbai - 400006, Maharashtra, India

Date of Birth/Age :

22.10.1966

Date of Appointment :

28.04.2004

PAN No.:

ADUPS8327F

DIN No.:

00157396

Other Directorship:

CIN/FCRN

COMPANY NAME

BEGIN DATE

END DATE

L24230MH1960PLC011586

ANUH PHARMA LIMITED

23/09/2016

-

U51102MH1983PTC029955

JAPOSHA TRADING PRIVATE LIMITED

22/07/1987

-

U24239MH1983PTC030195

S KANT PHARMA PRIVATE LIMITED

14/03/2007

-

U24239MH1983PTC030201

SEVANTILAL KANTILAL PRIVATE LIMITED

29/07/2008

-

U24230MH1990PTC057922

PRAGATI PHARMA PRIVATE LIMITED

29/08/1990

-

U24100MH2011PTC221911

ESKAY IODINE PRIVATE LIMITED

19/10/2011

-

U74900MH2014PTC255450

BEETLE VENTURES PRIVATE LIMITED

30/05/2016

-

U24304MH2017PTC292537

SKITES PHARMA PRIVATE LIMITED

16/03/2017

-

 

 

Name :

Ms. Lalit Popatlal Shah

Designation :

Director

Address :

B-2/2, Amalfi, 27 B, L. D. Ruparel Marg, Malabar Hill, Mumbai - 400006, Maharashtra, India

Date of Birth/Age :

02.10.1936

Date of Appointment :

18.03.1996

PAN No.:

AABPS7815C

DIN No.:

00396345

Other Directorship:

CIN/FCRN

COMPANY NAME

BEGIN DATE

END DATE

L24230MH1960PLC011586

ANUH PHARMA LIMITED

29/10/1980

-

U67120MH1983PTC029949

L P SHAH HOLDINGS AND TRADES PVT LTD

10/05/1983

-

U24239MH1983PTC030195

S KANT PHARMA PRIVATE LIMITED

31/03/1998

-

U24100MH2011PTC221911

ESKAY IODINE PRIVATE LIMITED

13/09/2011

-

 

 

Name :

Mr. Mahesh Kantilal Shah

Designation :

Director

Address :

37, Mahavir Building, B.G. Kher Marg, Malabar Hill, Mumbai - 400006, Maharashtra, India

Date of Birth/Age :

03.06.1949

Date of Appointment :

01.04.2001

PAN No.:

ADUPS8326E

DIN No.:

00506695

 

 

Name :

Mr. Ritesh Bipin Shah

Designation :

Director

Address :

1801, Devdarshan, 50, Ridge Road, Walkeshwar, Mumbai - 400006, Maharashtra, India

Date of Birth/Age :

01.01.1981

Date of Appointment :

01.10.2007

DIN No.:

02496729

Other Directorship:

CIN/FCRN

COMPANY NAME

BEGIN DATE

END DATE

L24230MH1960PLC011586

ANUH PHARMA LIMITED

23/09/2016

-

 

Name :

Mr. Mahesh Harishchandra Kolambe

Designation :

Wholetime Director

Address :

B/302, Surya Co-Operative Housing Society, Opposite Raj Residency, Chharwada Road, Vapi - 396195, Gujarat, India

Date of Birth/Age :

13.12.1975

Date of Appointment :

02.04.2013

DIN No.:

06544401

 

 

KEY EXECUTIVES

 

Name :

Mr. Roshan

Designation :

Office Executive

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders

 

No. of Shares

Samir Jayantilal Shah Joint Jasmine S. Shah

 

2400

Bharat N. Shah Joint Surekha B. Shah

 

2400

Mahesh K. Shah Joint Panna M. Shah Joint Rohan M. Shah

 

100

Jasmine S. Shah Joint Samir J. Shah

 

200

Panna M. Shah Joint Mahesh K. Shah Joint Rohan M. Shah

 

100

Harshit Bharat Shah

 

2170

Mrudula J. Shah Joint Samir J. Shah

 

1430

Surekha B. Shah Joint Harshit B. Shah

 

700

Krushank S. Shah

 

300

Total

 

9800

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 29.09.2017

 

Category

Percentage

Promoters- Individual/Hindu Undivided Family- Indian

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacture of medicinal substances used in the manufacture of pharmaceuticals antibiotics, endocrine products, basic vitamins, opium derivatives, sulpha drugs, serums and plasmas, salicylic acid, its salts and esters, glycosides and vegetable alkaloids, chemically pure suger etc. (Registered Activity)

 

 

Products / Services :

Name and Description of main products / services

NIC Code of the Product/service

Manufacturing Services on Physical inputs

Owned by Others

99884300

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information denied by the management

 

 

Bankers :

Banker Name :

HDFC Bank Limited

Branch :

HDFC Bank Housesenapati Bapat Marg, Lower Parel (West), Mumbai – 400013, Maharashtra, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Facilities :

(INR In Million)

SECURED LOAN

As on

31.03.2016

As on

31.03.2015

SHORT TERM BORROWING

 

 

Loans and advances from related parties

110.470

52.437

Loans and advances from directors

77.287

122.547

Total

187.757

174.984

 

 

Auditors :

 

Name :

S.I. Mogul and Company

Chartered Accountants

Address :

73-B, Mital Court, Nariman Point, Mumbai, Maharashtra, India

PAN N Income-tax PAN of auditor or auditor's firm :

AAMFS7435P

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises which are owned, have significant influence are partners with Key management personnel and their relatives:

·         Anuh Pharma Limited

L24230MH1960PLC011586

 

·         S Kant Pharma Private Limited

       U24239MH1983PTC030195

 

·         Eskay Iodine Private Limited

U24100MH2011PTC221911

 

·         S Kant Chemicals Private Limited

U24230MH1994PTC080562

 

·         Sevantilal Kantilal and Company

 

·         Bharti and Company

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

INR 1000/- each

INR 10.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9800

Equity Shares

INR 1000/- each

INR 9.800 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.      EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

9.800

9.800

9.800

(b) Reserves and Surplus

443.296

359.234

283.955

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

453.096

369.034

293.755

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

10.317

6.079

2.909

(c) Other long-term liabilities

0.000

0.000

0.000

(d) long-term provisions

1.614

1.447

1.357

Total Non-current Liabilities (3)

11.931

7.526

4.266

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

187.757

174.984

226.162

(b) Trade payables

239.638

200.987

265.448

(c) Other current liabilities

43.977

44.476

83.167

(d) Short-term provisions

23.234

31.925

41.008

Total Current Liabilities (4)

494.606

452.372

615.785

 

 

 

 

TOTAL

959.633

828.932

913.806

 

 

 

 

II.    ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

277.823

250.178

254.139

(ii) Intangible Assets

0.909

2.120

2.498

(iii) Tangible assets capital work-in-progress

13.460

0.370

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

5.867

5.706

5.706

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

298.059

258.374

262.343

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

177.941

137.971

110.440

(c) Trade receivables

190.285

248.995

301.810

(d) Cash and bank balances

102.805

42.280

51.668

(e) Short-term loans and advances

190.543

141.312

187.297

(f) Other current assets

0.000

0.000

0.248

Total Current Assets

661.574

570.558

651.463

 

 

 

 

TOTAL

959.633

828.932

913.806

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

1391.219

1136.773

1305.736

 

Other Income

3.801

6.713

9.053

 

TOTAL

1395.020

1143.486

1314.789

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

808.348

684.037

770.182

 

Purchases of Stock-in-Trade

83.028

34.481

24.739

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

3.657

(37.218)

14.737

 

Employee benefit expense

98.618

83.888

70.139

 

CSR expenditure

2.915

2.459

2.100

 

Other expenses

238.071

199.837

247.376

 

TOTAL

1234.637

967.484

1129.273

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

160.383

176.002

185.516

 

 

 

 

 

Less

FINANCIAL EXPENSES

7.630

17.073

15.737

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

152.753

158.929

169.779

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

45.769

48.045

53.191

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

106.984

110.884

116.588

 

 

 

 

 

Less

TAX

22.496

34.970

31.663

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

84.488

75.914

84.925

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

0.000

0.000

750.864

 

TOTAL EARNINGS

0.000

0.000

750.864

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

8621.22

7746.32

8665.81

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

0.000

0.000

0.000

Cash generated from operations

184.564

129.079

57.631

Net cash flows from (used in) operations

138.161

98.813

5.464

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

6.07

6.68

6.50

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

11.53

15.48

14.21

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

11.15

13.38

12.76

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.24

0.30

0.40

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.41

0.47

0.77

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

49.92

79.95

84.37

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

7.31

4.57

4.33

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

98.13

102.10

121.88

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.90

1.28

1.68

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

0.55

0.70

0.72

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

0.52

0.55

0.67

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

0.41

0.47

0.77

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

1.09

1.23

2.10

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.34

1.26

1.06

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.98

0.96

0.88

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.47

0.45

0.32

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

19.16

17.86

23.08

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.34

1.26

1.06

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

9.800

9.800

9.800

Reserves & Surplus

283.955

359.234

443.296

Net worth

293.755

369.034

453.096

 

 

 

 

Long-term borrowings

0.000

0.000

0.000

Short term borrowings

226.162

174.984

187.757

Total borrowings

226.162

174.984

187.757

Debt/Equity ratio

0.770

0.474

0.414

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1305.736

1136.773

1391.219

 

0.000

(12.940)

22.383

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1305.736

1136.773

1391.219

Profit/ (Loss)

84.925

75.914

84.488

 

6.50 %

6.68 %

6.07 %

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

STATE OF COMPANYS AFFAIRS AND FUTURE OUTLOOK

 

During the year the Company has achieved turnover of INR 1391.218 Million as compared to the last years turnover i.e. INR 1136.773 Million The net profit of the company during the year is INR 84.488 Million.

 

INDEX OF CHARGE:

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

C04639647

10495120

14/03/2014

-

-

225000000.0

HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WMUMBAIMH400013IN

2

B10412278

10279724

29/03/2011

-

-

50000000.0

PRINCESS STREET BRANCH, DEVKARAN MANSION,SHAMALDAS GANDHI MARG, PRINCESS STREET,MUMBAIMH400002IN

3

A89564298

10230972

24/06/2010

-

-

65000000.0

PRINCESS STREET BRANCH,DEVKARAN MANSION, SHAMALDAS GANDHI MARG,MUMBAIMH400002IN

4

A89564397

10136568

03/12/2008

24/06/2010

-

60000000.0

PRINCESS STREET BRANCH,DEVKARAN MANSION, SHAMALDAS GANDHI MARG,MUMBAIMH400002IN

5

A53822904

10136567

03/12/2008

-

-

15000000.0

PRINCESS STREET BRANCH,DEVKARAN MANSION, SHAMALDAS GANDHI MARG,MUMBAIMH400002IN

6

B08457038

80062443

10/02/2005

08/02/2011

-

371429000.0

PRINCESS STREET BRANCH,DEVKARAN MANSION, SHAMALDAS GANDHI MARG,MUMBAIMH400002IN

7

Y10246514

90146744

01/10/2004

-

-

58600000.0

PRINCESS STREET BRANCH; DEVKARAN MANSIONSAMALDAS GANDHI MARG; PRINCESS STREETMUMBAIMH400002IN

8

A89564504

90145433

01/10/2004

24/06/2010

-

22500000.0

PRINCESS STREET BRANCH,DEVKARAN MANSION, SHAMALDAS GANDHI MARG,MUMBAIMH400002IN

9

Y10242626

90142856

27/04/2000

-

16/10/2004

5000000.0

75; RASIK NIWASF-ROAD; MARINE DRIVEMUMBAIMH400020IN

10

Y10240548

90140778

27/04/2000

-

16/10/2004

9000000.0

75; RASIK NIWASF-ROAD; MARINE DRIVEMUMBAIMH400020I

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Furniture and Fixture

·         Office Equipment

·         Computer

·         Vehicles


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.07

UK Pound

1

INR 91.33

Euro

1

INR 80.03

 

 

INFORMATION DETAILS

 

Information Gathered by :

POO

 

 

Analysis Done by :

NIY

 

 

Report Prepared by :

NKTS

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.